Interactions between drugs and ginkgo or ginseng herbal medicines;Interações entre fármacos e medicamentos fitoterápicos à base de ginkgo ou ginseng

Revista Brasileira de Farmacognosia

Volumn 18, Issue 1, 2008, Pages 117-126

  Alexandre, Rodrigo F ^a   Bagatini, Fabíola ^a   Simões, Cláudia M O ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Drug herb interactions; Ginkgo; Ginkgo biloba; Ginseng; Panax ginseng

Indexed keywords

EID: 42249104838     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0102-695x2008000100021     Document Type: Article

References (97)

1. Alexandre RFA, Garcia, FN, Simões CMO 2005a. Fitoterapia baseada em evidências. Parte 1. Medicamentos fitoterápicos elaborados com ginkgo, hipérico, kava e valeriana. Acta Farma Bonaerense 24: 300-309.
2. Alexandre RFA, Garcia FN, Simões CMO 2005b. Fitoterapia baseada em evidências. Parte 2. Medicamentos fitoterápicos elaborados com alcachofra, castanha-daíndia, ginseng e maracujá. Acta Forma Bonaerense 24: 310-314.
3. Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Kirtas O 2005. The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia. Psychiatry Clin Neurosci 59: 652-656.
4. Barnes PM, Powell-Griner E, McFann K, Nahin RL 2004. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343: 1-19.
5. Bebbington A, Kulkarni R, Roberts P 2005. Ginkgo biloba: persistent bleeding after total hip arthroplasty caused by herbal self-medication. J Arthroplasty 20: 125-126.
6. Becker BN, Greene J, Evanson J, Chidsey G, Stone WJ 1996. Ginseng-induced diuretic resistance. JAMA 276: 606-607.
7. Blumenthal M, Goldberg A, Brinckmann J 2000. Herbal Medicine: Expanded commission e monographs. Austin: American Botanical Council.
8. Blumenthal M, Ferrier GKL, Cavaliere C 2006. Total sales of herbal supplements in United States show steady growth. Herbal Gram 71: 64-66.
9. Bucci L 2000. Selected herbals and human exercise performance. Am J Clin Nutr 72: 624-636.
10. Cheng TO 2005. Ginseng and other herbal medicines that interact with warfarin. Int J Cardiol 104: 227.
11. Cohen AJ, Bartlik B 1998. Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 24: 139-143.
12. Coleman CI, Hebert JH, Reddy P 2003. The effects of Panax ginseng on quality of life. J Clin Pharm Ther 28: 5-15.
13. Coon JT, Ernst E 2002. Panax ginseng: A systematic review of adverse effects and drug interactions. Drug Safety 25: 323-344.
14. Cordeiro CHC, Chung MC, Sacramento LVS 2005. Interações medicamentosas de fitoterápicos e fármacos: Hypericum perforatum z Piper methysticum. Rev Bras Farmacogn 15: 272-278.
15. De Smet PAGM 2005. Herbal medicine: relaxing regulatory standards. N Engl J Med 352: 1176-1178.
16. DeFeudis FV 1998. Ginkgo biloba extract (EGb 761) - From chemistry to the clinic. Wiesbaden: Ullstein Medical.
17. Drew S, Davies E 2001. Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ 322: 1-6.
18. Ernst E, Willooughby M, Weihmayr TH 1995. Nine possible reasons for choosing complementary medicine. Perfusion 8: 356-358.
19. Ernst E, Stevinson C 1999. Ginkgo biloba for tinnitus: a review. Clin Otolaryngol Allied Sci 24: 164-7.
20. Ernst E 2000a. Possible interactions between synthetic and herbal medicinal products Part 1: a systematic review of the indirect evidence. Perfusion 13: 4-15.
21. Ernst E 2000b. Interactions between synthetic and herbal medicinal products Part 2: a systematic review of the direct evidence. Perfusion 13: 60-70.
22. Fugh-Berman A 2000. Herb-drug interactions. Lancet 355: 134-138.
23. Fugh-Bernman A, Ernst E 2001. Herb-drug interactions: review and assessment of report reability. Br J Clin Pharmacol 52: 587-595.
24. Galluzzi S, Zanetti O, Trabucchi M, Frisoni GB 2000. Coma in a patient with Alzheimer's disease taking low-dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry 68: 679-680.
25. Gerhardt G, Rogalla K, Jaeger J 1990. Drug therapy of disorders of cerebral performance. Randomized comparative study of dihydroergotoxine and Ginkgo biloba extract. Fortschr Med 108: 384-388.
26. Granger AS 2001. Ginkgo biloba precipitating epileptic seizures. Age Ageing 30: 523-525.
27. Greenspan EM 1983. Ginseng and vaginal bleeding. JAMA 249:2018.
28. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A 2005. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 77: 415-426.
29. Hartel U, Volger E 2004. Use and acceptance of classical natural and alternative medicine in Germany - findings of a representative population-based survey. Forsch Komplementarmed Klass Naturheilkd 11: 327-334.
30. Hillebrand MD, Oliveira WF 2004. Efeito do EGB 761 (Extrato de Ginkgo biloba) sobre a qualidade de vida em pacientes asmáticos moderados submetidos a tratamento de manutenção. Rev Bras Farmacogn 14(Supl. 1): 24-26.
31. Hopfenmüller W 1994. Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age Arzneimittel-Forsch 44: 1005-1013.
32. Hu S, Concha C, Lin F, Persson Waller K 2003. Adjuvant effect of ginseng extracts on the immune responses to immunization against Staphylococcus aureus in dairy cattle. Vet Immunol Immunopathol 91: 29-37.
33. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S 2005. Herb-drug interactions: a literature review. Drugs 65: 1239-1282.
34. Ionnides C 2002. Pharmacocinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32: 451-478.
35. Izzo AA, Ernst E 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175.
36. Jacoby D, Mohler ER 2004. Drug treatment of intermittent claudication. Drugs 64: 1657-1670.
37. Janetzky K, Morrealy AP 1997. Probable interaction between warfarin and ginseng. Am J Health Syst Pharm 54: 692-693.
38. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ 2004. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 57: 592-9.
39. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ 2005. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 59: 425-32.
40. Jones BD, Runikis AM 1987. Interactions of ginseng with phenelzine. J Clin Psychopharmacol 7: 201-202.
41. Kang BJ, Lee SJ, Kim MD, Cho MJ 2002. A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum Psychopharmacol 17: 279-84.
42. Kim HJ, Chum YJ, Park JD, Kim SI, Roh JK, Jeong TC 1997. Protection of rat liver microsomes against carbon tethracloride-induced lipid peroxidation by red ginseng saponin through cytochrome P450 inhibition. Planta Med 63: 415-418.
43. Kimura M, Waki I, Chujo T, Kikuchi T, Hiyama C, Yamazaki K, Tanaka O 1981. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J Pharmacobiodyn 4: 410-7.
44. Kleijnen J, Knipschild P 1992. Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 34: 352-358.
45. Lambrecht JE, Hamilton W, Rabinovich A 2000. A review of herb-drug interations: documented and theoretical. US Pharma 25: 8
46. Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M 2002. Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGB 761® in Alzheimer's disease. Neuropsychobiology 45: 19-26.
47. Lee FC, Ko JH, Park JK, Lee JS 1987. Effects of Panax ginseng on blood alcohol clearance in man. Clin Exp Pharmacol Physiol 14: 543-546.
48. Liu CX, Xiao PG 1992. Recent advances on ginseng research in China. J Ethnopharmacol 36: 27-38.
49. MacLennan AH, Wilson DH, Taylor AW 1996. Prevalence and cost of alternative medicine in Australia. Lancet 347: 569-573.
50. Markowitz JS, Donovan JL, Lindsay DeVane C, Sipkes L, Chavin KD 2003. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 23: 576-81.
51. Matthews MK 1998. Association of Ginkgo biloba whit intracerebral hemorrhage. Neurolog 50: 1933-1934.
52. Meisel C, Johne A, Roots I 2003. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen. Atherosclerosis 167: 367.
53. Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R 2002. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol 58: 61-64.
54. Micromedex 2005. Drug-Reax Interactive Drug interactions 2005: Ginkgo. http://cdrompro.com.br/micromedex/trial.html, acessada em abril de 2005.
55. Micromedex 2006. Drug-Reax Interactive Drug Interactions: Ginseng 2006. http://cdrompro.com.br/micromedex/trial.html, acessada em: 27 de outubro de 2006.
56. Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, Guyatt G 2005. Natural health product-drug interactions: a systematic review of clinical trials. Ther Drug Monit 27: 549-557.
57. Momesso JC 2002. Análise do mercado nacional de fitoterápicos: Quais os passos, principals avanços, descobertas, capital movimentado e faturamento das indústrias de fitoterápicos. Palestra proferida em 27 de maio de 2002, São Paulo, SP, promovida pelo Institute for International Research do Brasil LTDA sobre o mercado de fitoterápicos.
58. Morgenstern C, Biermann E 2002. The efficacy of ginkgo special extract EGb 761 in patients with tinnitus. Int J Clin Pharmacol Ther 40: 188-197.
59. Ng TB, Yeung HW 1985. Hypoglycemic constituents of Panax ginseng. Gen Pharmacol 16: 549-552.
60. Ohnishi Y, Takagi S, Miura T, Usami M, Kako M, Ishihara E, Yano H, Tamgawa K, Seino Y 1996. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice. Biol Pharm Bull 19: 1238-1240.
61. Oken BS, Storzbach DM, Kaye JA 1998. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55: 1409-1415.
62. Palmer BV, Montgomery ACV, Monteiro JCMP 1978. Ginseng and mastalgia. BMJ 1: 1284.
63. Pittler MH, Ernst E 2000. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 108: 276-281.
64. Plotnikoff GA, McKenna D, Watanabe K, Blumenthal M 2004. Ginseng and warfarin interactions. Ann Intern Med 141: 891-894.
65. Prehn JH, Krieglstein J 1993. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34: 179-188.
66. Punnonen R, Lukola A 1980. Estrogen-like effect of ginseng. Lancet 181: 1110.
67. Rejali D, Sivakumar A, Balaji N 2004. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials. Clin Otolaryngol Allied Sci 29: 226-231.
68. Ribeiro AQ, Leite JPV, Dantas-Barros AM 2005. Perfil de utilização de fitoterápicos em farmácias comunitárias de Belo Horizonte sob a influência da legislação nacional. Rev Bras Farmacogn 15: 65-70.
69. Rogers SL, Farlow MR, Dooby RS, Mohs R, Friedhoff LT 1998. A 24-week, double-blind placebo-controlled trial of donezepil in patients with Alzheimer's disease. Neurology 50: 136-145.
70. Rosenblatt M, Mindel J 1997. Spontenous bilateral hyphema associated with ingestion of Ginkgo biloba extract. N Engl J Med 336: 1108.
71. Sasaki K, Hatta S, Haga M, Ohshika H 1999. Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain. Eur J Pharmacol 367: 165-173.
72. Scaglione F, Cattaneo G, Alessandria M, Cogo R 1996. Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 22: 65-72.
73. Schulz V 2003. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider. Phytomedicine 10: 74-79.
74. Shader RI, Greenblatt DJ 1985. Bees, ginseng and MAOIs revisited. J Clin Psychopharmacol 8: 235.
75. Shader RI, Greenblatt DJ 1988. Phenelzina and the dream machine-ramblings and reflections. J Clin Psychopharmacol 5: 65.
76. Silva MIG, Gondim APS, Nunes IFS, Sousa FCF 2006. Utilização de fitoterápicos nas unidades básicas de atenção à saúde da família no município de Maracanaú (CE). Rev Bras Farmacogn 16: 455-462.
77. Simões CMO, Mentz LA, Schenkel EP, Irgang BE, Stehmann JR 1986. Plantas da medicina popular no Rio Grande do Sul Porto Alegre: Editera da Universidade/UFRGS.
78. Smith M, Lin KM, Zheng YP 2001. PIII-89 an open trial of nifedipine-herb interactions : nifedipine with St John 's wort, ginseng or ginkgo biloba. Clin Pharmacol Ther 69: 86.
79. Smith PF, Zheng Y, Darlington CL 2005. Ginkgo biloba extracts for tinnitus: More hype than hope? J Ethnopharmacol 100: 95-99.
80. Sparreboom A, Cox MC, Acharya MR, Figg WD 2004. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol 22: 2489-2503.
81. van den Bout-van den Beukel CJ, Koopmans PP, van der Ven AJ, De Smet PA, Burger DM 2006. Possible drug-metabolism interactions of medicinal herbs with antiretroviral agents. Drug Metab Rev 38: 477-514.
82. Varona FJC, Morales MPA 2005. Ginkgo biloba y hemorragia cerebral. An Med Interna 22: 199.
83. Vogler BK, Pittler MH, Ernst E 1999. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 55: 567-575, 1999.
84. Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Xu Z 2000a. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23: 1221-1226.
85. Vuksan V, Sievenpiper JL, Koo VY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E 2000b. American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 160: 1009-13.
86. Vuksan V, Stavro MP, Sievenpiper JL, Koo VY, Wong E, Beljan-Zdravkovic U, Francis T, Jenkins AL, Leiter LA, Josse RG, Xu Z 2000c. American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation. J Am Coll Nutr 19: 738-744.
87. Vuksan V, Sievenpiper JL, Wong J, Xu Z, Beljan-Zdravkovic U, Arnason JT, Assinewe V, Stavro MP, Jenkins AL, Leiter LA, Francis T 2001. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. Am J Clin Nutr 73: 753-8.
88. Wettstein A 2000. Cholisterase inhibitors and ginkgo extracts -_are they comparable in the treatment of dementia? Comparasion of publish-placebo- controlled efficacy studies of at least six month's duration. Phytomedicine 6: 393-401.
89. Wheatley D 2004. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs. Hum Psychopharmacol 19: 545-548.
90. Williamson EM 2005. Interactions between herbal and conventional medicines 2005. Expert Opin Drug Saf 4: 355-378
91. Yin OQ, Tomlinson B, Waye MM, Chow AH, Chow MS 2004. Pharmacogenetics and herb-drug interactions: experience with Ginkgo biloba and omeprazole. Pharmacogenetics 14: 841-850.
92. Yoshioka M, Ohnishi N, Koishi T, Obata Y, Nakagawa M, Matsumoto T, Tagagi K, Takara K, Ohkuni T, Yokoyama T, Kuroda K 2004. Studies on interactions between functional foods or dietary supplements and medicines. IV. Effects of Ginkgo biloba leaf estract on the pharmacokinetics and pharmacodynamics of nifedipine in healthy volunteers. Biol Pharm Bull 27: 2006-2009.
93. Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, Kasza K, Ang-Lee M, Moss J 2004. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med 14: 23-27.
94. Zhang XY, Zhou DF, Su JM, Zhang PY 2001a. The effect of extract of Ginkgo biloba added to haloperidol on superoxide dismutase in inpatierits with chronic schizophrenia. J Clin Psychopharmacol 21: 85-8.
95. Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY 2001b. A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J Clin Psychiatry 62: 878-883.
96. Zhou D, Zhang X, Su J, Nan Z, Cui Y, Liu J, Guan Z, Zhang P, Shen Y 1999. The effects of classic antipsychotic haloperidol plus the extract of Ginkgo biloba on superoxide dismutase in patients with chronic refractory schizophrenia. Chin Med J 112: 1093-1096.
97. Zhu M, Chan KW, NG LS, Chang Q, Chang S, Li RC 1999. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 51: 175-180.